The fallout from the F.D.A.’s rejection of MDMA-assisted treatment for PTSD worries researchers and experts who fear other ...
The endTB trial is one of four recent randomized controlled trials testing new, shorter, and less toxic treatment regimens ...
There is an unmet need for therapies targeting Duchenne muscular dystrophy (DMD)–related heart disease, and phase 2 results ...
Vertex Pharmaceuticals on Thursday won approval from the Food and Drug Administration for a non-opioid pain drug, clearing ...
A third drug, pretomanid, received emergency authorization from the FDA for specific use within a regimen against highly drug ...
Adding lanreotide to everolimus significantly prolonged progression-free survival compared with everolimus alone in patients ...